Sign in

CIK 0000730272 · Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
042729386
Phone
7814499560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 4 Insider Changes in Ownership
  2. EFFECT Other Notice of Effectiveness
  3. 424B3 Offering Prospectus
  4. 144 Insider Sale of Securities
  5. S-4/A Deal Registration Statement - Business Combination
  6. 4 Insider Changes in Ownership
  7. S-4 Deal Registration Statement - Business Combination
  8. 4 Insider Changes in Ownership
  9. 144 Insider Sale of Securities
  10. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  11. 425 Deal Prospectus/Communication re Business Combination
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations
  15. 425 Deal Prospectus/Communication re Business Combination
  16. 425 Deal Prospectus/Communication re Business Combination
  17. 425 Deal Prospectus/Communication re Business Combination
  18. 8-K Event Material agreement · Results of operations · Regulation FD disclosure · Other events
  19. 4 Insider Changes in Ownership
  20. 144 Insider Sale of Securities

Page 2 of 69 · 1,379 filings